Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDASPHERE: Idarubicin-loaded Beads in HCC
NCT02870010Phase 1Completed
- Sponsor
- Centre Hospitalier Universitaire Dijon Bourgogne
- Start
- Feb 2010
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of idarubicin in hepatocellular carcinoma (HCC), sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Primary endpoint: Tolerance (Toxicities) at 2 months. Started Feb 2010; status: completed.
02
Drugs
idarubicin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02870010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02870010.